Sen. Josh Hawley, R-Mo., has lingering questions about President Donald Trump’s Centers for Medicare & Medicaid Services (CMS) nominee, Dr....
Read morePresident Donald Trump’s choice to lead the Food and Drug Administration (FDA), Johns Hopkins School of Medicine professor Dr. Marty Makary,...
Read moreThe House Judiciary Committee is expected to hold a hearing early next week looking into the issue of ‘activist judges,’...
Read moreA House Democrat who represents a district that former Vice President Kamala Harris lost to now-President Donald Trump in 2024...
Read moreThe Supreme Court heard arguments Monday on whether Louisiana lawmakers can use race as a factor when drawing congressional maps,...
Read moreThe recent arrest of Istanbul’s Mayor Ekrem İmamoğlu and main rival of President Erdoğan has sparked the largest protests in...
Read morePresident Donald Trump’s Cabinet outlined billions of dollars in contracts it says it has canceled since he took office, including...
Read morePresident Donald Trump has named Susan Monarez as his nominee for the next director of the Centers for Disease Control...
Read moreU.S. Attorney General Pam Bondi issued a stern warning to those engaged in government fraud at the most recent Cabinet...
Read moreSpeaker Mike Johnson, R-La., is expected to privately meet with Republican members of the House Judiciary Committee on Tuesday, two...
Read moreDisclaimer: EarningsMastery.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.